The Food and Drug Administration on Friday authorized Pfizer’s
coronavirus vaccine for use in the United States, clearing the way
for the biggest and most urgent immunization program in the
nation’s history.
[vc_row][vc_column][us_carousel post_type="ids" ids="260184, 260250, 107361" orderby="post__in" items_quantity="3" items_layout="11024" columns="3" items_gap="5px" overriding_link="post" breakpoint_1_cols="4" breakpoint_2_cols="3" breakpoint_3_cols="2"][/vc_column][/vc_row]
{
"slotId": "7483666091",
"unitType": "in-article",
"pubId": "pub-9300059770542025"
}
The vaccine is the first to be cleared for use in the U.S. The
FDA’s decision came one day after an independent FDA advisory
committee endorsed the shot for use in people age 16 and older,
based on clinical trial data that found the vaccine to be 95
percent effective with largely mild side effects.
The Pfizer vaccine had previously been authorized for use in the
United Kingdom and Canada.
